NCT01968551 · Interventional trial
Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults
Overall registry status Completed
Phase 3
Conditions Acquired Immunodeficiency Syndrome, HIV Infections, HIV-1
Delaware Valley sites
- Philadelphia FIGHT · Philadelphia, PA · Philadelphia County
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County
- University Of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory